Diagnostic yield of blood cultures from antibiotic-nave and antibiotically treated patients with haematological malignancies and high-risk neutropenia

Scandinavian Journal of Infectious Diseases

Volumn 41, Issue 9, 2009, Pages 650-655

  Hummel, Margit ^a   Warga, Christine ^a   Hof, Herbert ^a   Hehlmann, Ruediger ^a   Buchheidt, Dieter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ACUTE LEUKEMIA; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM IDENTIFICATION; BLOOD CULTURE; CANCER CHEMOTHERAPY; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; NEUTROPENIA; NONHUMAN; POPULATION RESEARCH; RISK ASSESSMENT;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHI-SQUARE DISTRIBUTION; FEMALE; FUNGEMIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HEMATOLOGIC NEOPLASMS; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; NEUTROPENIA; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION;

EID: 70849136831     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540903062150     Document Type: Article

References (22)

1. Link H, Bohme A, Cornely OA, Hoffken K, Kellner O, Kern WV, et al. Antimicrobial therapy of unexplained fever in neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society). Ann Hematol 2003;/82(Suppl 2):/S105-17.
2. Buchheidt D, Bohme A, Cornely OA, Fatkenheuer G, Fuhr HG, Heussel G, et al. Diagnosis and treatment of documented infections in neutropenic patients: recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Oncology (DGHO). Ann Hematol 2003;/82(Suppl 2):/S127-32. (Pubitemid 37265299)
3. Bodey GP. Infection in cancer patients: a continuing association. Am J Med 1986;/81:/11-26.
4. Elting LS, Rubenstein EB, Rolston KV, Bodey GP. Outcomes of bacteraemia in patients with cancer and neutropenia: observations from 2 decades of epidemiological and clinical trials. Clin Infect Dis 1997;/25:/247-59.
5. Klastersky J. Concept of empirical therapy with antibiotic combinations: indications and limits. Am J Med 1986;/80:/ 2-12.
6. Gram-positive bacteraemia in granulocytopenic cancer patients. EORTC International Antimicrobial Therapy Cooperative Group. Eur J Cancer 1990;26:569-574.
7. Warga C. Wertigkeit der Blutkulturdiagnostik bei febrilen neutropenischen Patienten mit akuter Leukämie und Patienten nach Hochdosistherapie und autologer Transplantation hämatopoetischer Stammzellen. Medizinische Dissertation, Fakultät für Klinische Medizin Mannheim, Ruprecht-Karls-Universität Heidelberg 2007.
8. Klastersky J, Glauser MP, Schimpff SC, Zinner SH, Gaya H. Prospective randomized comparison of 3 antibiotic regimens for empirical therapy of suspected bacteraemic infection in febrile granulocytopenic patients. Antimicrob Agents Chemother 1986;/29:/263-70.
9. Klastersky J, Zinner SH, Calandra T, Gaya H, Glauser MP, Meunier F, et al. Empirical antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from 4 EORTC trials. Eur J Cancer Clin Oncol 1988;/24(Suppl 1):/S35-45. (Pubitemid 18051215)
10. Viscoli C, Varnier O, Machetti M. Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification. Clin Infect Dis 2005;/40(Suppl 4):/S240-5.
11. Weinstein MP. Blood culture contamination: persisting problems and partial progress. J Clin Microbiol 2003;/41:/ 2275-2278.
12. Weinstein MP, Towns ML, Quartey SM, Mirrett S, Reimer LG, Parmigiani G, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteraemia and fungaemia in adults. Clin Infect Dis 1997;/24:/584-602.
13. Ortega M, Rovira M, Almela M, Marco F, de la Bellacasa JP, Martinez JA, et al. Bacterial and fungal bloodstream isolates from 796 haematopoietic stem cell transplant recipients between 1991 and 2000. Ann Hematol 2005;/84:/40-6.
14. Madani TA. Clinical infections and bloodstream isolates associated with fever in patients undergoing chemotherapy for acute myeloid leukaemia. Infection 2000;/28:/367-73.
15. Kern W, Kurrle E, Schmeiser T. Streptococcal bacteraemia in adult patients with leukaemia undergoing aggressive chemotherapy. A review of 55 cases. Infection 1990;/18:/ 138-145.
16. Awada A, van der Auwera P, Meunier F, Daneau D, Klastersky J. Streptococcal and enterococcal bacteraemia in patients with cancer. Clin Infect Dis 1992;/15:/33-48.
17. Richard V, Meunier F, van der AP, Dejace P, Daneau D, Klastersky J. Pneumococcal bacteraemia in cancer patients. Eur J Epidemiol 1988;/4:/242-5.
18. Elting LS, Bodey GP, Keefe BH. Septicaemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Dis 1992;/14:/1201-7.
19. Yadegarynia D, Tarrand J, Raad I, Rolston K. Current spectrum of bacterial infections in patients with cancer. Clin Infect Dis 2003;/37:/1144-5.
20. Wey SB, Mori M, Pfaller MA,Woolson RF, Wenzel RP. Risk factors for hospital acquired candidaemia: a matched casecontrol study. Arch Intern Med 1989;/149:/2349-53.
21. Komshian SV, Uwaydah AK, Sobel JD, Crane LR. Fungaemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 1989;/11:/379-90.
22. Rolston KV. Challenges in the treatment of infections caused by Gram-positive and Gram-negative bacteria in patients with cancer and neutropenia. Clin Infect Dis 2005;/40(Suppl 4):/S246-52.